Tiger Woods Gives Exclusive First Interview Since POWERED by FUSE Announcement!

AVENTURA, Fla., Nov. 21, 2011 /PRNewswire/ -- Double Eagle Holdings, Ltd. (OTCQB: DROP), the parent company of FUSE Science, Inc. (www.fusescience.com), announced last week a partnership with golf superstar Tiger Woods that will feature FUSE Science as the only sponsor on his bag. Woods and CEO of FUSE Science Adam Adler are set to conduct their first interview since announcing this partnership on CNBC today Monday, November 21, at 12:30 p.m. during an exclusive interview with Darren Rovell.

Since announcing that Tiger Woods is POWERED by FUSE Woods has enjoyed much success as he finished in third place at the 2011 Australian Open earlier this month and just yesterday he clinched the Presidents Cup win for the American team. On the last day of competition Woods put on a signature clutch performance as he sunk five birdies and powered out a deep bunker shot on the 15^th in winning the Presidents Cup.

On the heels of his big win at the Presidents Cup this weekend, Tiger Woods and Adam Adler are set for a press tour today kicking off with the CNBC interview in which they will discuss the newly formed partnership between Woods and FUSE Science. Discussion will also take place about the exciting news of the Tiger Woods POWERED by FUSE bag which he will use for the first time at the 2011 Chevron World Challenge, taking place Monday, Nov. 28 - Sunday, Dec. 4, 2011, at the Sherwood Country Club in Thousand Oaks, California.

About Double Eagle Holdings
Double Eagle Holdings (OTCQB: DROP) is the parent company of Fuse Science, Inc., an innovative consumer products holding company based in Aventura, Florida.  The corporate name, Double Eagle Holdings is in the process of being changed to Fuse Science Inc.  Fuse Science is the developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.  The company has successfully developed and maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly – all in a concentrated "DROP" form that is simply applied under the tongue.  The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products.  Information about Fuse Science is available online at www.fusescience.com or by calling 305-503-FUSE (3873).

Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.

SOURCE Double Eagle Holdings, Ltd.